Revolutionary new implant for dry age-related macular degeneration

Discover how a new implant has enabled patients with dry age-related macular degeneration (AMD) to read again.

With over 84% of trial participants regaining the ability to read letters, numbers, and words. Mahi Muqit, senior vitreoretinal consultant at Moorfields Eye Hospital and the Institute of Ophthalmology at UCL, joins our webinar to discuss the groundbreaking results from the PRIMA system clinical trial. Learn how the technology works and what this means for the future of treating patients with dry AMD and geographic atrophy